Neurotransmitter transporters are essential for terminating synaptic transmission by reuptaking neurotransmitters from the synaptic cleft. These transporters, which are sodium-dependent, are localized in synaptic membranes of neurons that use the same neurotransmitter and are crucial for synaptic signal termination. They are also important sites for drug action, particularly for cocaine and other stimulant drugs. Recent advances in molecular biology have enabled the cloning of these transporters, providing insights into their structure and function. Transporters such as the GABA, glutamate, and dopamine transporters have been studied extensively. The GABA transporter is sodium- and chloride-dependent and is involved in the reuptake of GABA. The dopamine transporter is a key target for cocaine and other stimulants. The serotonin transporter is also a target for antidepressants like fluoxetine and imipramine. These transporters are encoded by different genes and have distinct structural features, including multiple transmembrane domains and glycosylation sites. The structure of neurotransmitter transporters is highly conserved, with many sharing similar transmembrane domains and functional characteristics. The presence of 11–13 transmembrane domains is a common feature among these transporters. The GABA and dopamine transporters show significant sequence similarity, suggesting a common evolutionary origin. However, they differ in their specific functions and substrate preferences. The regulation of neurotransmitter transporters is influenced by various factors, including second messengers such as calcium and arachidonic acid. These messengers can modulate the activity of transporters, affecting the reuptake of neurotransmitters. Additionally, the expression of transporter genes is developmentally regulated and can be influenced by synaptic activity and other environmental factors. Overall, the study of neurotransmitter transporters has provided valuable insights into the mechanisms of synaptic signaling and the role of these transporters in drug action. The availability of cloned transporter genes and the development of new molecular tools have enabled further research into the structure and function of these transporters, leading to a better understanding of their role in neurological disorders and drug effects.Neurotransmitter transporters are essential for terminating synaptic transmission by reuptaking neurotransmitters from the synaptic cleft. These transporters, which are sodium-dependent, are localized in synaptic membranes of neurons that use the same neurotransmitter and are crucial for synaptic signal termination. They are also important sites for drug action, particularly for cocaine and other stimulant drugs. Recent advances in molecular biology have enabled the cloning of these transporters, providing insights into their structure and function. Transporters such as the GABA, glutamate, and dopamine transporters have been studied extensively. The GABA transporter is sodium- and chloride-dependent and is involved in the reuptake of GABA. The dopamine transporter is a key target for cocaine and other stimulants. The serotonin transporter is also a target for antidepressants like fluoxetine and imipramine. These transporters are encoded by different genes and have distinct structural features, including multiple transmembrane domains and glycosylation sites. The structure of neurotransmitter transporters is highly conserved, with many sharing similar transmembrane domains and functional characteristics. The presence of 11–13 transmembrane domains is a common feature among these transporters. The GABA and dopamine transporters show significant sequence similarity, suggesting a common evolutionary origin. However, they differ in their specific functions and substrate preferences. The regulation of neurotransmitter transporters is influenced by various factors, including second messengers such as calcium and arachidonic acid. These messengers can modulate the activity of transporters, affecting the reuptake of neurotransmitters. Additionally, the expression of transporter genes is developmentally regulated and can be influenced by synaptic activity and other environmental factors. Overall, the study of neurotransmitter transporters has provided valuable insights into the mechanisms of synaptic signaling and the role of these transporters in drug action. The availability of cloned transporter genes and the development of new molecular tools have enabled further research into the structure and function of these transporters, leading to a better understanding of their role in neurological disorders and drug effects.